The best road to recovery is the one that focuses on technology, especially through testing. Since the pandemic erupted a year ago, COVID-19 tests have evolved. Initiatives like those from the National Institutes of Health (NIH) enable smart tech to process results and allow mobile labs to get them anywhere. They are much more instantaneous than they used to be.

In fact, this tech has helped the U.S. increase from thousands of tests per day to 2.7 million toward the end of last year. More tests and faster results allow people to quarantine and social distance properly, slowing the spread.

Further, new developments are in the works for at-home testing. Despite the increase of vaccinations on a national scale, testing will still be vital for the U.S. and global recovery. The best way to continue testing without risking spreading the virus is with instant, at-home tests.

Recently, the Biden administration announced buying these tests from Australian health care production company Ellume. The deal involves initially providing the U.S. with 8.5 million tests, with plans to reach 19 million per month. Though manufacturing on this scale will take several months to set up and achieve, it's a promising tech approach that increases testing in the U.S.

This partnership will likely bring on a new wave of at-home testing, where people get results instantly without needing a doctor's approval. One area that will need to change, though, is the cost of $30 per test.

DevinPartida

Username: DevinPartida

Facebook Comments